ED
55
3
UA
59
2
LEG
35
6
NFLX
55
-2
RCL
77
-4
EQT
54
3
DVA
75
2
XRX
55
3
CI
65
3
NWS
47
2
LB
30
-4
NTAP
60
-4
WU
32
2
UHS
59
-8
ILMN
42
-4
WBA
27
8
AVGO
69
-7
NWL
57
3
FAST
46
-2
WMB
62
2
ED
55
3
UA
59
2
LEG
35
6
NFLX
55
-2
RCL
77
-4
EQT
54
3
DVA
75
2
XRX
55
3
CI
65
3
NWS
47
2
LB
30
-4
NTAP
60
-4
WU
32
2
UHS
59
-8
ILMN
42
-4
WBA
27
8
AVGO
69
-7
NWL
57
3
FAST
46
-2
WMB
62
2
Financhill
Back

Brainstorm Cell Therapeutics Vs. ResMed Industry Stock Comparison

Sell
19

BCLI
Brainstorm Cell Therapeutics

Last Price:
0.22
Seasonality Move:
-19.05%
Sell
37

RMD
ResMed

Last Price:
238.89
Seasonality Move:
9.63%
Sell
19
Brainstorm Cell Therapeutics (BCLI) is a Sell

Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?

  • The current Brainstorm Cell Therapeutics [BCLI] share price is $0.22. The Score for BCLI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • BCLI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
ResMed (RMD) is a Sell

Is ResMed a Buy, Sell or Hold?

  • The current ResMed [RMD] share price is $239.00. The Score for RMD is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • RMD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCLI Stock Price Chart

What is Brainstorm Cell Therapeutics's stock price today?

  • The Brainstorm Cell Therapeutics share price today is $0.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing selling pressure, which indicates risk of future bearish movement.

RMD Stock Price Chart

What is ResMed's stock price today?

  • The ResMed share price today is $239.00
    The current trend is moderately bearish and RMD is experiencing selling pressure, which indicates risk of future bearish movement.

BCLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 33.97 Sell
Chaikin Money Flow: -447720 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.24 - 0.3) Sell
Bollinger Bands (100): (0.28 - 0.46) Sell

RMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.17 Buy
Relative Strength Index (14 RSI): 48.53 Sell
Chaikin Money Flow: -1050033 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (237.55 - 250.79) Sell
Bollinger Bands (100): (200 - 236.14) Buy

BCLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.24 Sell
20-day SMA: 0.26 Sell
50-day SMA: 0.3 Sell
200-day SMA: 0.38 Sell
8-day EMA: 0.24 Sell
20-day EMA: 0.26 Sell
50-day EMA: 0.3 Sell
200-day EMA: 0.5 Sell

RMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 242.7 Sell
20-day SMA: 246.18 Sell
50-day SMA: 229.88 Buy
200-day SMA: 201.27 Buy
8-day EMA: 243.22 Sell
20-day EMA: 242.45 Sell
50-day EMA: 232.43 Buy
200-day EMA: 208.09 Buy

Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and a decrease next year of $0.02 per share.

ResMed Earnings Growth & RMD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.05 per share, an increase this year of $1.19 per share, and an increase next year of $1.40 per share.

Brainstorm Cell Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ResMed Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):